NSTK · 01.2026Independent supplement reference
NutriStack
Edition 1.0Updated August 1, 2026

Supplement × Prescription·Evidence index

Benazepril and Potassium: what the published research says

PubMed indexes 4 records that name Benazepril and Potassium together, either in the title or in an interaction, co-administration, or pharmacokinetic context. Each one is listed below with its study design and, where the abstract states one, the authors’ own conclusion, quoted and linked. This page reports that literature. It does not tell you whether to combine them.

Read this first

An evidence index, not guidance.

Every statement below is attributed to a named, dated, linked source.

This page lists published research relevant to Benazepril and Potassium. It deliberately does not state whether the combination is safe, whether it interacts, in which direction, at what dose, or how far apart to take them.

The research

4 studies naming Benazepril and Potassium.

Strongest relevance first: papers naming both substances in the title, then human trials and systematic reviews.

Efficacy of Losartan Potassium and Benazepril in Hypertensive Patients With Insulin Resistance: Impact on Blood Pressure, Insulin Sensitivity, and Diabetes Risk.

Cureus · 2025 · PMID 40255834

“Conclusions LP was more effective than benazepril in lowering blood pressure and improving insulin sensitivity, which may contribute to a lower diabetes risk in hypertensive patients with IR. A randomized controlled trial with longer follow-up is recommended to confirm these findings and assess long-term metabolic outcomes.”

Chaudhary et al. · From the abstract

Names both Benazepril and Potassium in its title.

Safety of the combination of valsartan and benazepril in patients with chronic renal disease. European Group for the Investigation of Valsartan in Chronic Renal Disease.

Journal of hypertension · 2000 · PMID 10678548

Clinical TrialMulticenter StudyRandomized Controlled Trial

“These results indicate that short-term combination of an angiotensin-converting enzyme inhibitor and an angiotensin receptor blocker is safe and well tolerated in patients with moderate chronic renal failure.”

Ruilope et al. · Authors' conclusion

Names Benazepril and Potassium together in an interaction, co-administration, or pharmacokinetic context.

Effects of benazepril and hydrochlorothiazide, given alone and in low- and high-dose combinations, on blood pressure in patients with hypertension.

Archives of family medicine · 1996 · PMID 8542050

Clinical TrialMulticenter StudyRandomized Controlled Trial

“Benazepril in combination with hydrochlorothiazide, including a low-dose combination of 5/6.25 mg, is effective in reducing sitting diastolic and systolic blood pressure in patients with hypertension.”

Chrysant et al. · Authors' conclusion

Names Benazepril and Potassium together in an interaction, co-administration, or pharmacokinetic context.

Limitations

What this evidence cannot tell you.

Search-based evidence indexes have real limits, and it is worth being explicit about them:

NutriStack

Track what you actually take.

NutriStack is a free iPhone app for organising a supplement routine: what you take, when, and what the published record says about it. Its exploratory interaction checker covers Benazepril, Potassium, and several hundred other substances.

The checker is a research and organisation tool, not a clinical decision aid, and its per-pair assessments are excluded from search until they pass claim-level review.

NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.